Nebivolol Hydrochloride

Drug Usage Statistics, United States, 2008 - 2018

Nebivolol Hydrochloride Summary for 2018

Estimated number of prescriptions in the United States 2,955,158
Top drug rank #191 ( 47)
Average total drug cost $232.78 (USD)
Average out-of-pocket cost $41.52 (USD)

Number of Prescriptions Over Time (2008 - 2018)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2008 340 -
2009 276  64
2010 172  104
2011 91  81
2012 98  7
2013 172  74
Year Rank Change
2014 141  31
2015 150  9
2016 126  24
2017 144  18
2018 191  47

Drug Cost Over Time (2008 - 2018)

  • Total cost: The average total cost of the medication including the out-of-pocket cost (see below) plus the amount paid by other parties (Medicare, Medicaid, private insurance, Veterans Administration, TRICARE, other state/federal sources, Worker's compensation, and other miscellaneous sources)
  • Out-of-pocket cost: The average payment made by the patient which may include deductibles, coinsurance, copayments, or the cash price paid without insurance coverage.

Related Drugs

Drug Name Total Prescriptions (2018)
Metoprolol 71,581,961
Carvedilol 22,737,639
Atenolol 18,644,885
Propranolol Hydrochloride 14,571,768
Timolol 4,312,018
Nebivolol Hydrochloride (this drug) 2,955,158
Labetalol 2,297,672
Dorzolamide Hydrochloride; Timolol Maleate 1,950,346
Bisoprolol Fumarate; Hydrochlorothiazide 1,556,623
Bisoprolol Fumarate 1,396,798

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Bystolic
Generic Drug Synonyms and Salts
  • Nebivolol Hydrochloride

FDA Approval Information

Established Pharmacologic Class (EPC): beta-Adrenergic Blocker
Initial FDA approval date: 12/17/2007
First FDA applicant: Rx
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2008-2018. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 21.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

 
©2020 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Nov 19, 2020
Back to Top
Top